François-Xavier Goudot
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
François-Xavier Goudot has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Christophe Meune
Cardiology Department, Avicenne University Hospital, APHP, Université Sorbonne Paris Nord, Bobigny, France
3 shared publications Adrian Lazureanu
Cardiology Department , Avicenne University Hospital, APHP, Université Sorbonne Paris Nord , Bobigny , France
1 shared publicationCamille Chenevier-Gobeaux
Automated Biological Diagnosis Department , Cochin University Hospital, APHP.Centre – Université de Paris , Paris , France
1 shared publicationCamille Chenevier‐Gobeaux
Automated Biological Diagnosis Department Cochin University Hospital APHP Centre Université de Paris Paris France
1 shared publicationCarla Sleiman
Department of Cardiology, Avicenne Hospital, Hopitaux Universitaires Paris-Seine-Saint-Denis, APHP, France
1 shared publication- Charlotte Cohen
Avicenne Hosp, Clin Cardiol, Bobigny, France
1 shared publication
Latest Publications
- Open Access
- 18 December 2023
- Published by EDP Sciences in médecine/sciences
- Vol. 39 (12) , 975-980
Le prélèvement d’organes de type Maastricht 3
Médecine/sciences (M/S), revue internationale dans le domaine de la recherche biologique, médicale et en santé
- 18 December 2023
- Published by EDP Sciences in médecine/sciences
- Vol. 39 (12) , 975-980
Open AccessLe prélèvement d’organes de type Maastricht 3
Médecine/sciences (M/S), revue internationale dans le domaine de la recherche biologique, médicale et en santé
- 29 March 2022
- Published by Hindawi Limited in Journal of Clinical Pharmacy and Therapeutics
- Vol. 47 (8) , 1212-1217
Real‐life contemporary vitamin K antagonist is still associated with very low time in therapeutic range despite strict international normalized ratio monitoring: Results of big data analysis
What is known and objective This study aimed to determine the results of INR monitoring in patients on vitamin K antagonists (VKAs) and the time in therapeutic range (TTR) in 'real-world' settings. Methods Retrospective analysis of 836,857 INR measurements performed in adults from February 2010 to August 2015 in two districts in the French Brittany region. Results Of the 836,857 INR measurements, 94.9% were ordered by general practitioners and 2.0% by cardiologists. The number of tests increased by 10-year age categories up to the age-group of 80-90 years. The number of INR measurements increased from 169,636 in 2011 to 176,184 in 2012, but then decreased slightly to 162,597 in 2013 and 164,427 in 2014. Mean coefficient of variation of INR was 19.0%, and mean TTR was 29.0%. TTR was higher in women than in men (31% vs. 18%), in older than in younger patients (19.1% at 40 years and 38.6% at 100 years) and in patients with arrhythmias than in those with deep vein thrombosis/pulmonary embolism (44.4% versus 19.4%) (p < 10(-5) for each comparison). Median interval between INR measurements was 14 days [7-28]; it was prolonged in men vs women, rural vs urban regions, older vs younger patients and when requested by GPs vs cardiologists. The interval was shorter for patients with INR outside the therapeutic range versus patients with INR within the therapeutic range (9 days [5-21] vs. 18 days [10-29], p < 10(-10)). What is new and conclusion VKAs are still frequently prescribed in this era of direct oral anticoagulants. The low TTR cannot be explained by inadequate INR monitoring.
- 29 March 2022
- Published by Hindawi Limited in Journal of Clinical Pharmacy and Therapeutics
- Vol. 47 (8) , 1212-1217
Real‐life contemporary vitamin K antagonist is still associated with very low time in therapeutic range despite strict international normalized ratio monitoring: Results of big data analysis
What is known and objective This study aimed to determine the results of INR monitoring in patients on vitamin K antagonists (VKAs) and the time in therapeutic range (TTR) in 'real-world' settings. Methods Retrospective analysis of 836,857 INR measurements performed in adults from February 2010 to August 2015 in two districts in the French Brittany region. Results Of the 836,857 INR measurements, 94.9% were ordered by general practitioners and 2.0% by cardiologists. The number of tests increased by 10-year age categories up to the age-group of 80-90 years. The number of INR measurements increased from 169,636 in 2011 to 176,184 in 2012, but then decreased slightly to 162,597 in 2013 and 164,427 in 2014. Mean coefficient of variation of INR was 19.0%, and mean TTR was 29.0%. TTR was higher in women than in men (31% vs. 18%), in older than in younger patients (19.1% at 40 years and 38.6% at 100 years) and in patients with arrhythmias than in those with deep vein thrombosis/pulmonary embolism (44.4% versus 19.4%) (p < 10(-5) for each comparison). Median interval between INR measurements was 14 days [7-28]; it was prolonged in men vs women, rural vs urban regions, older vs younger patients and when requested by GPs vs cardiologists. The interval was shorter for patients with INR outside the therapeutic range versus patients with INR within the therapeutic range (9 days [5-21] vs. 18 days [10-29], p < 10(-10)). What is new and conclusion VKAs are still frequently prescribed in this era of direct oral anticoagulants. The low TTR cannot be explained by inadequate INR monitoring.
- 23 June 2021
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 59 (12) , e461-e464
NT-proBNP use in old patients and the impact of the selected threshold value: a big data analysis
Article NT-proBNP use in old patients and the impact of the selected threshold value: a big data analysis was published on November 1, 2021 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 59, issue 12).
- 23 June 2021
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 59 (12) , e461-e464
NT-proBNP use in old patients and the impact of the selected threshold value: a big data analysis
Article NT-proBNP use in old patients and the impact of the selected threshold value: a big data analysis was published on November 1, 2021 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 59, issue 12).
- 26 March 2021
- Published by Galenos Yayinevi in European Journal of Geriatrics and Gerontology
- Vol. 3 (1) , 18-24
Characteristics and Outcomes of Frail Patients Hospitalised with Cardiovascular Diseases
- 26 March 2021
- Published by Galenos Yayinevi in European Journal of Geriatrics and Gerontology
- Vol. 3 (1) , 18-24
Characteristics and Outcomes of Frail Patients Hospitalised with Cardiovascular Diseases
- 1 July 2020
- Published by Elsevier in Soins Gérontologie
- Vol. 25 (144) , 38-42
Patient âgé insuffisant cardiaque, qualité ou quantité de vie ?
- 1 July 2020
- Published by Elsevier in Soins Gérontologie
- Vol. 25 (144) , 38-42
Patient âgé insuffisant cardiaque, qualité ou quantité de vie ?
- 1 March 2014
- Published by Elsevier in International Journal of Cardiology
- Vol. 172 (1) , e69-e70
Delayed cardiac tamponade following management of a massive hemothorax related to a penetrating thoracic trauma
- 1 March 2014
- Published by Elsevier in International Journal of Cardiology
- Vol. 172 (1) , e69-e70
Delayed cardiac tamponade following management of a massive hemothorax related to a penetrating thoracic trauma